tiprankstipranks
Haemonetics price target raised to $103 from $94 at Barrington
The Fly

Haemonetics price target raised to $103 from $94 at Barrington

Barrington analyst Michael Petusky raised the firm’s price target on Haemonetics to $103 from $94 and keeps an Outperform rating on the shares following the fiscal Q3 beat. The company reported a strong Q3 and also significantly increased the lower end of its previously provided fiscal 2023 outlook, the analyst tells investors in a research note.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on HAE:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles